Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (for routine co-testing in women over 30)
2000136
Copy Utility
Copied!
Choose the Right Test
ARUP Consult® assists with test selection and interpretation
Recommendations when to order or not order the test. May include related or preferred tests.
FDA-approved test for cotesting at 5-year intervals in individuals 25-65 years with a cervix. Preferred test is Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (3003005).
Mnemonic
Unique test identifier.
TH REQUEST
Methodology
Process(es) used to perform the test.
Microscopy/Qualitative Nucleic Acid Amplification
Performed
Days of the week the test is performed.
Sun-Sat
Reported
Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-7 days, add 2 days for HPV testing
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect
Cervical specimen in a ThinPrep Pap Test collection kit, broom kit (ARUP Supply #12587) or brush/spatula kit (ARUP Supply #40624) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787.
Specimen Preparation
Transport cervical specimen in the original collection kit.
Storage/Transport Temperature
Room temperature.
Unacceptable Conditions
Specimens not collected in a ThinPrep Pap Test collection kit or specimens submitted in an expired collection kit.
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Interpretive Data
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Refer to report.
Compliance Category
FDA
Note
Additional information related to the test.
In addition to the ThinPrep Pap Test, Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (ARUP test code 3003005) will be performed and reported under a separate accession. Additional charges apply. The Pap Test is a screening test for cervical cancer and its precursors with an inherent false-negative rate.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
88142; if reviewed by pathologist add 88141; 87624
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
Cytology
Pap
Pap Smear
Thin Prep reflex HPV
ThinPrep
ThinPrep Pap
ThinPrep Pap and HPV HR E6/E7
ThinPrep Pap Test with reflex to HR HPV
ThinPrep Reflex to HPV
Cytology, ThinPrep Pap Test and Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by Nucleic Acid Amplification (NAA), ThinPrep (for routine co-testing in women over 30)
Chat
Feedback
